Actual status of AIDS-related lymphoma management in Japan

Int J Hematol. 2008 May;87(4):442-443. doi: 10.1007/s12185-008-0073-8.

Authors

Hirokazu Nagai¹, Nami Iwasaki², Takashi Odawara³, Seiji Okada⁴

Affiliations

¹ Clinical Research Center, National Hospital Organization Nagoya Medical Center, 4-1-1 Sannomaru, Naka-ku, Nagoya, 460-0001, Japan. nagaih@nnh.hosp.go.jp.
² Clinical Research Center, National Hospital Organization Nagoya Medical Center, 4-1-1 Sannomaru, Naka-ku, Nagoya, 460-0001, Japan.
³ The Institute of Medical Science, University of Tokyo, Tokyo, Japan.
⁴ Center for AIDS Research, Kumamoto University, Kumamoto, Japan.

PMID: 18389175
DOI: 10.1007/s12185-008-0073-8

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Antibodies, Monoclonal / immunology
Antibodies, Monoclonal / therapeutic use
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents / therapeutic use
Humans
Immunotherapy
Japan / epidemiology
Lymphoma, AIDS-Related / epidemiology
Lymphoma, AIDS-Related / etiology*
Lymphoma, AIDS-Related / immunology
Lymphoma, AIDS-Related / therapy*
Rituximab

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents
Rituximab